A new fluid biomarker for Parkinson’s disease (PD) was developed, offering a high-accuracy biological classification, ...

Researchers have identified a key enzyme driving forms of Parkinson’s, and have shown how blocking it restores normal function in animal and cell models – offering a promising new drug target for the ...

Scientists examined microscopic blobs of protein found in human cells has discovered that some morph from an almost honey-like substance to a hard candy-like solid. These mysterious droplets, known as ...

At the end of 2021, for example, Novartis paid $150 million upfront for rights to an orally-active alpha-synuclein candidate in phase 2 development at UCB in a deal that could be worth $1.5 billion.

The Marathon closed alpha is starting this week, and players will be given what will ultimately feel like a short window to experience the game. If you received a code, you will want to make sure ...

Paris-based sales outfit Alpha Violet has acquired world distribution rights to “Caravan,” a first feature by Czech director Zuzana Kirchnerová about a mother and her disabled son who embark ...

A phase 2 trial of Lundbeck’s alpha-synuclein-targeting drug Lu AF82422 has failed to reach statistical significance in patients with multiple system atrophy (MSA), although the company says the ...

Rusev interrupted a segment between the New Day and The Alpha Academy. Otis and Tozawa were looking for a shot at the newly won World Tag Team Champions of Kofi Kingston and Xavier Woods ...

I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from Seeking Alpha). I have no business relationship with any company whose stock ...